Document is current
Any future updates will be listed below
-
Authors
Gradel, Kim Oren https://orcid.org/0000-0002-5611-2031
Anru, Pavithra Laxsen https://orcid.org/0000-0002-7046-2556
Nielsen, Stig Lønberg https://orcid.org/0000-0002-7780-7131
Skovmand, Sofie https://orcid.org/0000-0001-9314-1360
Dessau, Ram Benny https://orcid.org/0000-0002-1497-6309
Møller, Jens Kjølseth https://orcid.org/0000-0002-5547-5498
Andersen, Steen Lomborg https://orcid.org/0009-0009-2157-6555
Jensen, Thøger Gorm https://orcid.org/0000-0002-3889-0016
Coia, John Eugenio https://orcid.org/0000-0002-4966-8453
Søgaard, Mette https://orcid.org/0000-0002-2830-4968
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 30 October 2025
First Online: 12 November 2025
Declarations
:
: As the study was registry-based and without patient contact, approval from an ethics committee or consent from participants is not required according to Danish law. However, because microbiology data are legally considered to be medical chart data, we needed permission to use these (Danish Patient Safety Authority, Rec. No. 3–3013-945/1 and 3–3013-945/2). The project was listed in the Region of Southern Denmark’s record (Rec. No. 24/14678).
: Not applicable.
: Financial interests: R.B.D.: Advisory board Meeting, Pfizer, September 2022 and 2024 concerning Borrelia vac-cination. J.E.C.: Participated in an advisory board and as a speaker at sessions organized by Tillotts Pharma AG. Other authors: no conflicts of interest. Non-financial interests: All authors, no conflicts of interest.
